Fig. 3From: Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi ArabiaBootstrap Distribution of Cost-Effectiveness: Comparative Analysis between Risankizumab and Adalimumab Incorporating Real Utilization Rates and CostsBack to article page